Celltrion
068270.KS
#801
Rank
$24.56 B
Marketcap
$118.62
Share price
-0.60%
Change (1 day)
-1.66%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): $0.50 Billion USD

According to Celltrion 's latest financial reports the company's current earnings are $1.97 Billion USD. In 2023 the company made an earning of $0.51 Billion USD, an increase over its 2022 earnings that were of $0.48 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.50 B-2.29%
2023 $0.51 B6.8%
2022 $0.48 B-21.85%
2021 $0.61 B10.25%
2020 $0.55 B65.16%
2019 $0.33 B16.64%
2018 $0.28 B-33.89%
2017 $0.43 B106.53%
2016 $0.21 B25.57%
2015 $0.16 B-6.54%
2014 $0.18 B47.36%
2013 $0.12 B-33.63%
2012 $0.18 B
2010 $95.83 M72.84%
2009 $55.44 M260.54%
2008 $15.37 M